Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Express Scripts
Baxter
McKinsey
Boehringer Ingelheim

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Patent Applications for temozolomide

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

US Patent Applications for temozolomide

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial METHOD, APPARATUS AND SYSTEM FOR USE IN TREATING PATIENT WITH A DRUG HAVING AN ANTINEOPLASTIC EFFECT TO OPTIMIZE THERAPY AND PREVENT AN ADVERSE DRUG RESPONSE 2001-03-26 Patented Case 2003-06-05
  Start Trial   Start Trial PHARMACEUTICAL COMPOSITION FOR AND METHOD OF TREATING LEUKEMIA 2001-02-23 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2011-05-23
  Start Trial   Start Trial Protection of hematopoietic cells by the induction of post-mitotic quiescence 2001-06-18 Abandoned -- Failure to Respond to an Office Action 2003-07-08
  Start Trial   Start Trial IMMUNOSTIMULATORY NUCLEIC ACIDS FOR INDUCING A TH2 IMMUNE RESPONSE 2001-01-22 Abandoned -- Failure to Respond to an Office Action 2006-03-20
  Start Trial   Start Trial TYROSINE KINASE INHIBITORS 2001-02-20 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2014-08-11
  Start Trial   Start Trial Tyrosine kinase inhibitors 2001-02-20 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2009-12-07
  Start Trial   Start Trial METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF NEOPLASIA 2001-05-21 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2014-11-17
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
McKinsey
Mallinckrodt
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.